Progress of Artemisinin production in East Africa

1
Progress of Artemisinin production in East Africa

• Advanced Bio- Extracts Limited
• Lisa Amenya

2
Perspective - who we are...

• Advanced Bio- Extracts Limited (ABE)
• Private company with four production subsidiaries
  operating in the East Africa region
• African Artemisia Limited (Tanzania)
• East African Botanicals Limited (Kenya)
• East African Botanicals U Limited (Uganda)
• Botanical Extracts EPZ Limited (Kenya)

3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
Objectives

• To create a predictable, affordable supply of
  artemisinin and derivatives feeding into the
  ACT chain.
• To inject a significant supply of artemisinin to
  solve industry shortfalls within a 2- year
  period.
• To contribute significantly to bringing the whole
  chain of ACT production to Africa, in a
  sustainable way.

7
Progress on production of artemisinin in East
Africa

• Can production in East Africa be competitive?
  Under the right conditions YES
• Raw material
• Stable supply being built up rapidly.
• Using a range of farming patterns in East Africa.
  
• Processing
• Producing and selling small commercial quantities
  of artemisinin.
• Will be supplying more significant commercial
  quantities of artemisinin by year end 2006.
• About to commission a major artemisinin
  processing and extraction plant in Kenya.
• Production of artemisinin based derivatives from
  the Kenya plant by mid- 2007.

8
Small scale production
9
Large scale production
10
Satellite extraction plant, Uganda
11
Crude artemisinin
12
Pure artemisinin
13
What we are offering

• Supply of artemisinin and derivatives at
  predictable volumes and prices.
• To work with other extractors to purify and
  derivative their products.
• Long- term relationships with growers.

14
Challenges

• Market certainty clarification of synthetics.
• Much more complicated than it appears.
• Economy of scale required.
• To overcome technical challenges for cost
  effectiveness
• Too much fragmentation will not enhance
  viability.
• Focus on comparative advantages of the region.
• Financial support for technical development and
  investment.